Solved

-Prime Pharmaceuticals Has Developed a New Asthma Medicine, for Which

Question 498

Multiple Choice

-Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if Prime Pharmaceuticals could perfectly price discriminate, then consumer surplus would equal A) $64 million. B) $16 million. C) $32 million. D) zero.
-Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if Prime Pharmaceuticals could perfectly price discriminate, then consumer surplus would equal


A) $64 million.
B) $16 million.
C) $32 million.
D) zero.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Q493: If a natural monopoly does NOT inflate

Q494: Price discrimination, where different units of a

Q495: An industry in which economies of scale

Q496: Which of the following is a characteristic

Q497: The social interest theory of regulation suggests

Q499: Which of the following is LEAST likely

Q500: Price cap regulation is a<br>A) price ceiling.<br>B)

Q501: If a natural monopoly is regulated using

Q502: <img src="https://d2lvgg3v3hfg70.cloudfront.net/TB8586/.jpg" alt=" -Consider the monopolist

Q503: Rate of return regulation sets the price